vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与Lantheus Holdings, Inc.（LNTH）财务数据对比。点击上方公司名可切换其他公司
Lantheus Holdings, Inc.的季度营收约是COMPASS MINERALS INTERNATIONAL INC的1.0倍（$406.8M vs $396.1M），Lantheus Holdings, Inc.净利率更高（13.3% vs 4.7%，领先8.6%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs 4.0%），Lantheus Holdings, Inc.自由现金流更多（$81.4M vs $-59.8M），过去两年Lantheus Holdings, Inc.的营收复合增速更高（4.9% vs 4.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
CMP vs LNTH — 直观对比
营收规模更大
LNTH
是对方的1.0倍
$396.1M
营收增速更快
CMP
高出24.9%
4.0%
净利率更高
LNTH
高出8.6%
4.7%
自由现金流更多
LNTH
多$141.2M
$-59.8M
两年增速更快
LNTH
近两年复合增速
4.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $406.8M |
| 净利润 | $18.6M | $54.1M |
| 毛利率 | 16.0% | 59.2% |
| 营业利润率 | 9.2% | 19.0% |
| 净利率 | 4.7% | 13.3% |
| 营收同比 | 28.9% | 4.0% |
| 净利润同比 | 178.8% | 558.8% |
| 每股收益（稀释后） | $0.43 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMPLNTH
| Q4 25 | $396.1M | $406.8M | ||
| Q3 25 | $227.5M | $384.0M | ||
| Q2 25 | $214.6M | $378.0M | ||
| Q1 25 | $494.6M | $372.8M | ||
| Q4 24 | $307.2M | $391.1M | ||
| Q3 24 | $208.8M | $378.7M | ||
| Q2 24 | $202.9M | $394.1M | ||
| Q1 24 | $364.0M | $370.0M |
净利润CMPLNTH
| Q4 25 | $18.6M | $54.1M | ||
| Q3 25 | $-7.2M | $27.8M | ||
| Q2 25 | $-17.0M | $78.8M | ||
| Q1 25 | $-32.0M | $72.9M | ||
| Q4 24 | $-23.6M | $-11.8M | ||
| Q3 24 | $-48.3M | $131.1M | ||
| Q2 24 | $-43.6M | $62.1M | ||
| Q1 24 | $-38.9M | $131.1M |
毛利率CMPLNTH
| Q4 25 | 16.0% | 59.2% | ||
| Q3 25 | 16.9% | 57.9% | ||
| Q2 25 | 19.2% | 63.8% | ||
| Q1 25 | 15.5% | 63.8% | ||
| Q4 24 | 11.2% | 63.5% | ||
| Q3 24 | 9.3% | 63.9% | ||
| Q2 24 | 16.1% | 64.9% | ||
| Q1 24 | 19.7% | 65.4% |
营业利润率CMPLNTH
| Q4 25 | 9.2% | 19.0% | ||
| Q3 25 | 5.3% | 11.4% | ||
| Q2 25 | 7.4% | 23.3% | ||
| Q1 25 | -0.6% | 27.4% | ||
| Q4 24 | 0.2% | 29.1% | ||
| Q3 24 | -14.3% | 35.3% | ||
| Q2 24 | 2.9% | 26.1% | ||
| Q1 24 | -10.8% | 28.8% |
净利率CMPLNTH
| Q4 25 | 4.7% | 13.3% | ||
| Q3 25 | -3.2% | 7.2% | ||
| Q2 25 | -7.9% | 20.8% | ||
| Q1 25 | -6.5% | 19.6% | ||
| Q4 24 | -7.7% | -3.0% | ||
| Q3 24 | -23.1% | 34.6% | ||
| Q2 24 | -21.5% | 15.8% | ||
| Q1 24 | -10.7% | 35.4% |
每股收益（稀释后）CMPLNTH
| Q4 25 | $0.43 | $0.86 | ||
| Q3 25 | — | $0.41 | ||
| Q2 25 | $-0.41 | $1.12 | ||
| Q1 25 | $-0.77 | $1.02 | ||
| Q4 24 | $-0.57 | $-0.18 | ||
| Q3 24 | $-1.17 | $1.79 | ||
| Q2 24 | $-1.05 | $0.88 | ||
| Q1 24 | $-0.94 | $1.87 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $359.1M |
| 总债务越低越好 | $890.0M | $568.7M |
| 股东权益账面价值 | $260.5M | $1.1B |
| 总资产 | $1.5B | $2.2B |
| 负债/权益比越低杠杆越低 | 3.42× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资CMPLNTH
| Q4 25 | $46.7M | $359.1M | ||
| Q3 25 | $59.7M | $382.0M | ||
| Q2 25 | $79.4M | $695.6M | ||
| Q1 25 | $49.5M | $938.5M | ||
| Q4 24 | $45.8M | $912.8M | ||
| Q3 24 | $20.2M | $866.4M | ||
| Q2 24 | $12.8M | $757.0M | ||
| Q1 24 | $38.3M | $718.3M |
总债务CMPLNTH
| Q4 25 | $890.0M | $568.7M | ||
| Q3 25 | $839.8M | $567.9M | ||
| Q2 25 | $833.4M | $566.8M | ||
| Q1 25 | $807.6M | $566.1M | ||
| Q4 24 | $974.4M | $565.3M | ||
| Q3 24 | $921.2M | $613.0K | ||
| Q2 24 | $875.1M | $563.2M | ||
| Q1 24 | $877.2M | $562.5M |
股东权益CMPLNTH
| Q4 25 | $260.5M | $1.1B | ||
| Q3 25 | $234.1M | $1.1B | ||
| Q2 25 | $249.8M | $1.2B | ||
| Q1 25 | $236.5M | $1.2B | ||
| Q4 24 | $263.0M | $1.1B | ||
| Q3 24 | $316.6M | $1.2B | ||
| Q2 24 | $352.1M | $1.0B | ||
| Q1 24 | $400.4M | $945.5M |
总资产CMPLNTH
| Q4 25 | $1.5B | $2.2B | ||
| Q3 25 | $1.5B | $2.3B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.1B | ||
| Q4 24 | $1.7B | $2.0B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.6B | $1.9B | ||
| Q1 24 | $1.7B | $1.8B |
负债/权益比CMPLNTH
| Q4 25 | 3.42× | 0.52× | ||
| Q3 25 | 3.59× | 0.51× | ||
| Q2 25 | 3.34× | 0.49× | ||
| Q1 25 | 3.41× | 0.49× | ||
| Q4 24 | 3.70× | 0.52× | ||
| Q3 24 | 2.91× | 0.00× | ||
| Q2 24 | 2.49× | 0.55× | ||
| Q1 24 | 2.19× | 0.59× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $90.2M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $81.4M |
| 自由现金流率自由现金流/营收 | -15.1% | 20.0% |
| 资本支出强度资本支出/营收 | 5.8% | 2.2% |
| 现金转化率经营现金流/净利润 | -1.99× | 1.67× |
| 过去12个月自由现金流最近4个季度 | $94.1M | $354.1M |
8季度趋势，按日历期对齐
经营现金流CMPLNTH
| Q4 25 | $-37.0M | $90.2M | ||
| Q3 25 | $-6.9M | $105.3M | ||
| Q2 25 | $21.8M | $87.1M | ||
| Q1 25 | $186.9M | $107.6M | ||
| Q4 24 | $-4.1M | $157.7M | ||
| Q3 24 | $-12.7M | $175.1M | ||
| Q2 24 | $-6.8M | $84.7M | ||
| Q1 24 | $86.2M | $127.2M |
自由现金流CMPLNTH
| Q4 25 | $-59.8M | $81.4M | ||
| Q3 25 | $-22.8M | $94.7M | ||
| Q2 25 | $3.8M | $79.1M | ||
| Q1 25 | $172.9M | $98.8M | ||
| Q4 24 | $-25.9M | $141.4M | ||
| Q3 24 | $-33.6M | $159.3M | ||
| Q2 24 | $-21.5M | $73.5M | ||
| Q1 24 | $56.2M | $119.0M |
自由现金流率CMPLNTH
| Q4 25 | -15.1% | 20.0% | ||
| Q3 25 | -10.0% | 24.7% | ||
| Q2 25 | 1.8% | 20.9% | ||
| Q1 25 | 35.0% | 26.5% | ||
| Q4 24 | -8.4% | 36.1% | ||
| Q3 24 | -16.1% | 42.0% | ||
| Q2 24 | -10.6% | 18.7% | ||
| Q1 24 | 15.4% | 32.2% |
资本支出强度CMPLNTH
| Q4 25 | 5.8% | 2.2% | ||
| Q3 25 | 7.0% | 2.8% | ||
| Q2 25 | 8.4% | 2.1% | ||
| Q1 25 | 2.8% | 2.3% | ||
| Q4 24 | 7.1% | 4.2% | ||
| Q3 24 | 10.0% | 4.2% | ||
| Q2 24 | 7.2% | 2.8% | ||
| Q1 24 | 8.2% | 2.2% |
现金转化率CMPLNTH
| Q4 25 | -1.99× | 1.67× | ||
| Q3 25 | — | 3.79× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 1.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 0.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
